Floatz logo

Seroquel®

Parkinson's Disease Psychosis

VA Office of Research and DevelopmentPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Parkinson's Disease Psychosis cohort.

Asset / SponsorPhaseRating
Acp-103
Tasly Pharmaceutical Group Co., Ltd
Phase 4BBB

Same molecule, other indications

Seroquel® is also rated in:

substance abuseDormant
BBB
Indicative ·
78 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
77 / 100
View asset →
mood disorderDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →